Novel approaches to the design of bioavailable melanotropins

Yang Zhou, Minying Cai

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: The melanocortin system is a primordial and critical system for survival, involved in a wide variety of physiological functions. It includes melanocortin receptors (MCRs) and melanotropin ligands (MCLs). MCRs are important drug targets that can regulate several key physiological processes. Extensive efforts have been made to develop peptide and peptidomimetics targeting melanocortin receptors including MC1R, MC3R, MC4R and MC5R. Most research is focused on developing potent and selective melanotropins. However, developing bioavailable melanotropins remains challenging. Areas covered: Herein, the authors summarize promising strategies for developing bioavailable MCLs by using cyclized N-methylated melanotropins, and using cyclotide and tetrapeptide as templates. They discuss their unique advantages in oral availability and targeting MCRs in the central nervous system or in peripheral tissues. Finally, they discuss the observed differences in thepharmacology of MCRs between in vitro and in vivo tests. Expert opinion: N-methylated cyclized melanotropins have great potential to become bio- available drugs targeting MCRs in the brain, while MCR-grafted cyclotides tend to target MCRs in peripheral tissue. A better understanding of the biased signaling process is a new challenge and opportunity for the future discovery of bioavailable MCLs.

Original languageEnglish (US)
Pages (from-to)1023-1030
Number of pages8
JournalExpert Opinion on Drug Discovery
Volume12
Issue number10
DOIs
StatePublished - Oct 3 2017

Fingerprint

Melanocortin Receptors
Melanocyte-Stimulating Hormones
Cyclotides
Ligands
Melanocortins
Physiological Phenomena
Peptidomimetics
Expert Testimony
Drug Delivery Systems
Central Nervous System
Peptides

Keywords

  • bioavailable peptide
  • cyclized peptide
  • cyclotide
  • N-methylated peptide

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Novel approaches to the design of bioavailable melanotropins. / Zhou, Yang; Cai, Minying.

In: Expert Opinion on Drug Discovery, Vol. 12, No. 10, 03.10.2017, p. 1023-1030.

Research output: Contribution to journalReview article

@article{1a6b14ba82de4be59778209f87c192e4,
title = "Novel approaches to the design of bioavailable melanotropins",
abstract = "Introduction: The melanocortin system is a primordial and critical system for survival, involved in a wide variety of physiological functions. It includes melanocortin receptors (MCRs) and melanotropin ligands (MCLs). MCRs are important drug targets that can regulate several key physiological processes. Extensive efforts have been made to develop peptide and peptidomimetics targeting melanocortin receptors including MC1R, MC3R, MC4R and MC5R. Most research is focused on developing potent and selective melanotropins. However, developing bioavailable melanotropins remains challenging. Areas covered: Herein, the authors summarize promising strategies for developing bioavailable MCLs by using cyclized N-methylated melanotropins, and using cyclotide and tetrapeptide as templates. They discuss their unique advantages in oral availability and targeting MCRs in the central nervous system or in peripheral tissues. Finally, they discuss the observed differences in thepharmacology of MCRs between in vitro and in vivo tests. Expert opinion: N-methylated cyclized melanotropins have great potential to become bio- available drugs targeting MCRs in the brain, while MCR-grafted cyclotides tend to target MCRs in peripheral tissue. A better understanding of the biased signaling process is a new challenge and opportunity for the future discovery of bioavailable MCLs.",
keywords = "bioavailable peptide, cyclized peptide, cyclotide, N-methylated peptide",
author = "Yang Zhou and Minying Cai",
year = "2017",
month = "10",
day = "3",
doi = "10.1080/17460441.2017.1351940",
language = "English (US)",
volume = "12",
pages = "1023--1030",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Novel approaches to the design of bioavailable melanotropins

AU - Zhou, Yang

AU - Cai, Minying

PY - 2017/10/3

Y1 - 2017/10/3

N2 - Introduction: The melanocortin system is a primordial and critical system for survival, involved in a wide variety of physiological functions. It includes melanocortin receptors (MCRs) and melanotropin ligands (MCLs). MCRs are important drug targets that can regulate several key physiological processes. Extensive efforts have been made to develop peptide and peptidomimetics targeting melanocortin receptors including MC1R, MC3R, MC4R and MC5R. Most research is focused on developing potent and selective melanotropins. However, developing bioavailable melanotropins remains challenging. Areas covered: Herein, the authors summarize promising strategies for developing bioavailable MCLs by using cyclized N-methylated melanotropins, and using cyclotide and tetrapeptide as templates. They discuss their unique advantages in oral availability and targeting MCRs in the central nervous system or in peripheral tissues. Finally, they discuss the observed differences in thepharmacology of MCRs between in vitro and in vivo tests. Expert opinion: N-methylated cyclized melanotropins have great potential to become bio- available drugs targeting MCRs in the brain, while MCR-grafted cyclotides tend to target MCRs in peripheral tissue. A better understanding of the biased signaling process is a new challenge and opportunity for the future discovery of bioavailable MCLs.

AB - Introduction: The melanocortin system is a primordial and critical system for survival, involved in a wide variety of physiological functions. It includes melanocortin receptors (MCRs) and melanotropin ligands (MCLs). MCRs are important drug targets that can regulate several key physiological processes. Extensive efforts have been made to develop peptide and peptidomimetics targeting melanocortin receptors including MC1R, MC3R, MC4R and MC5R. Most research is focused on developing potent and selective melanotropins. However, developing bioavailable melanotropins remains challenging. Areas covered: Herein, the authors summarize promising strategies for developing bioavailable MCLs by using cyclized N-methylated melanotropins, and using cyclotide and tetrapeptide as templates. They discuss their unique advantages in oral availability and targeting MCRs in the central nervous system or in peripheral tissues. Finally, they discuss the observed differences in thepharmacology of MCRs between in vitro and in vivo tests. Expert opinion: N-methylated cyclized melanotropins have great potential to become bio- available drugs targeting MCRs in the brain, while MCR-grafted cyclotides tend to target MCRs in peripheral tissue. A better understanding of the biased signaling process is a new challenge and opportunity for the future discovery of bioavailable MCLs.

KW - bioavailable peptide

KW - cyclized peptide

KW - cyclotide

KW - N-methylated peptide

UR - http://www.scopus.com/inward/record.url?scp=85028744129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028744129&partnerID=8YFLogxK

U2 - 10.1080/17460441.2017.1351940

DO - 10.1080/17460441.2017.1351940

M3 - Review article

C2 - 28699792

AN - SCOPUS:85028744129

VL - 12

SP - 1023

EP - 1030

JO - Expert Opinion on Drug Discovery

JF - Expert Opinion on Drug Discovery

SN - 1746-0441

IS - 10

ER -